Iconocast Logo

Welcome To Iconocast

How to add a URL link from your web site to the Iconocast web sites

Virtual tour of Southern California



 

Recent News and Articles on the Keywords: seems + study + angioplasty  Related to the article below (Last Update: 8/4/2008)

Angioplasty should be regulated tightly
Cherry Hill Courier Post, NJ - Jul 26, 2008
That seems incredible, but that is exactly the experiment. In angioplasty, a catheter is inserted into the body and a balloon tip or stent is used to open a ...
Cerebral angioplasty does not improve outcomes after subarachnoid ...
Medicexchange, UK - Jul 11, 2008
Dr. Zwienenberg-Lee and colleagues in The Balloon Prophylaxis for Aneurysmal Vasospasm (BPAV) Study Group evaluated the efficacy of prophylactic PTBA in a ...

Sydney Morning Herald
Make sure the beat goes on
Sydney Morning Herald, Australia - Jul 23, 2008
"Nowadays it's almost indefensible not to place a patient who has had heart disease, heart attack, surgery or angioplasty onto a statin drug before they ...
Ivivi Technologies, Inc. F4Q08 (Qtr End 3/31/08) Earnings Call ...
Seeking Alpha, NY - Jul 21, 2008
These were patients who could not for a variety of reasons undergo surgical procedures such as bypass, stenting, or angioplasty. The patients in the active ...IVVI
St. John officials voice opposition to new cardiac rules
Longview Daily News, WA - Jul 8, 2008
State officials said they developed the rules after doing an independent study and consulting healthcare providers. The proposed 300 angioplasty standard ...
Use of Coated Stents on the Rise, But How Safe Are They?
Newsinferno.com, NY - Jul 16, 2008
Some stents have a drug coating meant to keep vessels from re-clogging following balloon angioplasty procedures. Bare-metal stents tend to re-clog more ...
Source: Google News

Long-term Effects of Angiopeptin Treatment in Coronary Angioplasty Reduction of Clinical Events but … -
H Emanuelsson, KJ Beatt, JP Bagger, R Balcon, J … - Circulation, 1995 - Am Heart Assoc
... that occurs after coronary angioplasty is myointimal ... and angiographic variables may
seem inconsistent and ... In this study, standardization of the angiographic ...

… Transluminal Coronary Angioplasty by the Radial, Brachial and Femoral Approaches: The Access Study -
F Kiemeneij, MD, PhD, GJ Laarman, MD, PhD, D … - Journal of the American College of Cardiology, 1997 - Elsevier
... of outpatient transradial balloon angioplasty in patients ... The study will also include
a cost ... femoral diagnostic coronary angiography seems straightforward with ...

[PDF] Randomised comparison of primary stent placement versus primary angioplasty followed by selective … -
E Tetteroo, Y van der Graaf, JL Bosch, AD van … - Lancet, 1998 - share.eldoc.ub.rug.nl
... between the treatment methods, primary angioplasty followed by ... particularly since
the strategy also seems the most ... placement (65 [38%] of 169 in our study). ...
-

… treated with primary angioplasty for acute myocardial infarction The glucose-insulin-potassium study -
ICC van der Horst, F Zijlstra, AWJ van't Hof, CJM … - Journal of the American College of Cardiology, 2003 - Am Coll Cardio Found
... therapy to PTCA in acute MI seems promising. ... reperfusion in patients treated with
primary angioplasty for acute ... Zwolle Myocardial Infarction study group. ...

angioplasty Results of the glycoprotein receptor antagonist patency evaluation (GRAPE) pilot study -
LFM van den Merkhof, F Zijlstra, H Olsson, L Grip, … - Journal of the American College of Cardiology, 1999 - Am Coll Cardio Found
... Activator in Occluded Arteries (GUSTO)-IIb Angioplasty Substudy (17 ... in the classic
TIMI-1 (16) study and the ... 8,9). Interestingly, in Figure 2 there seems to be ...

… with amlodipine after angioplasty: results from the coronary AngioPlasty Amlodipine REStenosis Study -
B Jorgensen, S Simonsen, K Endresen, K Forfang, K … - Journal of the American College of Cardiology, 2000 - Am Coll Cardio Found
... after percutaneous transluminal coronary angioplasty (PTCA) compromises the ... has been
extensively studied and seems to be ... have been done to study prevention of ...

… for the Reduction of Restenosis After Percutaneous Transluminal Coronary Angioplasty The EMPAR Study -
JA Cairns, J Gill, B Morton, R Roberts, M Gent, J … - Circulation, 1996 - Am Heart Assoc
... in the present study. It therefore seems clear that the biochemical changes resulting
from fish oil supplementation do not lead to a reduction in angioplasty ...

… Reduces Constrictive Arterial Remodeling After Balloon Angioplasty A Study in the Atherosclerotic … -
BJGL de Smet, D de Kleijn, R Hanemaaijer, JH … - Circulation, 2000 - Am Heart Assoc
... The principal finding of the present study was that ... Arterial remodeling after balloon
angioplasty has been recognized as a ... to shrinkage, the latter seems to be ...

Angioplasty Combined with Primary Stenting Versus Balloon Angioplasty Alone in Femoropopliteal … -
D Vroegindeweij - CardioVascular and Interventional Radiology, 1997 - Springer
... coagulation therapy was strictly used in our patients it seems that intravascular ...
balloon angioplasty alone [14 ... [15] reported in a retrospective study the value ...

… elective coronary balloon angioplasty in patients with end stage renal disease: a case-control study -
FC Schoebel, F Gradaus, K Ivens, P Heering, TW Jax … - British Medical Journal, 1997 - heart.bmj.com
... Design A retrospective case-control study of 20 patients ... that minimum luminal diameter
before angioplasty (r = 0.79 ... with end stage renal disease seems to be ...

Source: Google Scholar
 
 

Study says late angioplasty seems futile

November 15, 2006 04:43:05 AM PST

New research has overturned one of the most fundamental beliefs among doctors treating heart attacks: that opening a blocked artery is always a good idea, even days or weeks later.

Instead, the study revealed that doing this too late may not help, and there were disturbing hints that it might even be harmful. People who had balloon angioplasty to open an artery three to 28 days after their heart attacks fared no better than those given standard medicines to prevent a second attack.

The results don't apply to most Americans suffering a heart attack, but suggest that 100,000 of them a year might be able to skip the expense and risk of angioplasty and take medications instead, doctors said.

"These findings were really a surprise," said Dr. Elizabeth Nabel, director of the National Heart, Lung and Blood Institute, which funded the large international study. "For a long time we thought that opening up the artery any time after a heart attack was better than leaving it closed. My guess is you may see some guideline recommendations" on what to do in such situations, she said.

Opening arteries quickly is crucial to surviving heart attacks, and the study's findings do not change the need for urgent action or the evidence that angioplasty saves lives when done soon after an attack.

Nearly 1 million heart attacks occur in the United States each year, typically when a vessel squeezes shut, preventing enough blood and oxygen from reaching the heart.

The usual treatment is angioplasty, in which doctors snake a tube through a blood vessel in the groin to the blockage. A tiny balloon is inflated and a mesh stent is put in place to prop the artery open.

But one-third of heart attack victims do not seek care within 12 hours, when angioplasty has the best chance of helping. Clot-dissolving drugs don't always work. No guidelines say what to do in such situations, but most doctors assumed that an angioplasty, even if done late, still would help prevent further damage to the heart muscle and future attacks.

This bias was so strong that the study took more than five years to recruit enough patients because doctors were unwilling to risk randomly assigning some of them to drug treatment alone, said Dr. Judith Hochman, cardiovascular research chief at New York University School of Medicine.

Some studies suggested "that if you left the hospital with an open artery, you did better over the long term," but this had never been firmly tested, said Hochman, who led the new study and gave results Tuesday at an American Heart Association conference. They also were published online by the New England Journal of Medicine and will appear in its Dec. 7 issue.

Researchers enrolled 2,166 people in 27 countries to get either angioplasty three to 28 days after their heart attack and standard drug treatment — medicines to lower blood pressure and cholesterol, and aspirin and other anti-clotting drugs — or medicines alone.

These were patients who had survived their original heart attack but had a single vessel completely blocked, yet were stable because the heart was still receiving sufficient blood and oxygen from other vessels.

Four years later, 17 percent of those given angioplasty and drugs and nearly 16 percent of those given drugs alone had either died, suffered another heart attack or developed heart failure — results considered to be statistically the same.

There was a worrisome trend toward more heart attacks in the angioplasty group — 7 percent vs. 5 percent of the others — as time went on, though this could have been a statistical fluke, Hochman said.

The lack of benefit from angioplasty was not because the procedure didn't work — it successfully reopened arteries more than 90 percent of the time, Hochman said.

Instead, the findings suggest that once a blocked vessel had caused a heart attack, opening it was no better than taking standard medications for preventing future problems.

"There is a reason to rethink angioplasty" in such situations, said Dr. Timothy Gardner, a cardiologist at Christiana Care Health Services in Wilmington, Del., and chairman of the Heart Association program committee that reviewed the research.

Angioplasty did seem to help prevent chest pain years after the procedure, Hochman said.

Most people have angioplasties in non-emergency situations to relieve chest pain and this research does not apply to them.

The new study underscores the importance of fast medical help for heart attacks.

"It is critical to seek medical care quickly. Don't deny that something is happening. Don't sit at home and take antacids," Hochman said.

A dozen or so companies donated drugs and devices for the study and many of the researchers have consulted for them. The federal government paid 94 percent of the study's cost.

___

On the Net:

Heart association: http://www.americanheart.org

New England Journal: http://www.nejm.org

Article continues below and (thank you)

 

Stem cells show versatility

November 15, 2006 11:27:19 AM PST

Stem cells are once again showing their versatility.

One new study finds that they can ease symptoms of muscular dystrophy in dogs, a possible lead for human therapy, while another finds that stem cells recovered from amniotic fluid can be used to grow heart valves.

Both studies used so-called "adult" stem cells, which are found in the tissues of humans and animals. Much of the controversy has focused on "embryonic" human stem cells, which appear about five days after conception when the embryo is a hollow ball smaller than a grain of sand. Embryos must be destroyed to retrieve these stem cells, and that has provoked ethical opposition.

Stem cells are prized for their ability to give rise to a range of types of tissue. Many scientists say embryonic stem cells are generally more versatile than adult cells, although they continue to explore the possibilities of adult stem cells.

A long-term goal is to grow replacement tissue for treating conditions like diabetes and Parkinson's disease. Some scientists also hope to use embryonic stem cells that have disease-linked genetic defects for studying the very earliest steps in complex illnesses. That work could offer insights for finding new treatments.

 

Stem cell injections help dogs with MS

November 15, 2006 10:00:43 AM PST

In promising new research, stem cells worked remarkably well at easing symptoms of muscular dystrophy in dogs, an experiment that experts call a significant step toward treating people.

"It's a great breakthrough for all of us working on stem cells for muscular dystrophy," said researcher Johnny Huard of the University of Pittsburgh, who wasn't involved in the work.

Sharon Hesterlee, vice president of translational research at the Muscular Dystrophy Association, called the result one of the most exciting she's seen in her eight years with the organization. Her group helped pay for the work.

She stressed that it's not yet clear whether such a treatment would work in people, but said she had "cautious optimism" about it.

Two dogs that were severely disabled by the disease were able to walk faster and even jump after the treatments.

The study was published online Wednesday by the journal Nature. It used stem cells taken from the affected dogs or other dogs, rather than from embryos. For human use, the idea of using such "adult" stem cells from humans would avoid the controversial method of destroying human embryos to obtain stem cells.

The Nature paper focuses on Duchenne muscular dystrophy, a muscle-wasting genetic disorder that occurs in about 1 in every 3,500 male births. It's the most severe and most common childhood form of muscular dystrophy and the best-known. In theory, the stem cell treatment might also help other muscle dystrophies or even age-related muscle wasting, Hesterlee said.

Children with the disorder have trouble walking as early as preschool, and nearly all of them lose their ability to walk between ages 7 and 12. Typically, they die in their 20s because of weakness in their heart and lung muscles. There is no known cure.

The dog study was done by Giulio Cossu, director of the stem cell institute at the San Raffaele Scientific Institute in Milan, Italy, with colleagues there and elsewhere.

"We do not know whether this will work in patients," Cossu said in a telephone interview. He said he hopes to start a small experiment in children in the next year or two.

The scientists worked with golden retrievers that suffer a crippling form of dystrophy very much like the human one. Researchers studied the effect of repeated injections into the bloodstream of a kind of stem cell extracted from blood vessel walls.

The best results appeared when the cells were taken from healthy dogs. But Cossu said scientists should pursue the possibility of genetically manipulating a patient's own cells and using them instead. That way, patients wouldn't have to undergo lifelong treatment to avoid rejection of donated cells.

In one of several experiments, three dogs that had not yet shown impairment in walking were injected five times, a month apart, with cells taken from other dogs.

One dog completely avoided symptoms and continued to walk well even five months after both the injections and the anti-rejection therapy were stopped.

A second dog also did well initially but died suddenly of a heart problem after just two months on the treatment. It's not clear whether the problem had anything to do with the treatment, or whether the initial good result would have continued, Cossu said.

The third dog showed partial protection, being able to walk and even run with a limp, but then progressively lost walking ability within a few days after the anti-rejection treatment was stopped.

The researchers also treated two dogs that were severely impaired by the disease. Both gained the ability to move much faster and to jump, and one was even able to run, although neither could use the hind legs normally.

One of these dogs rapidly lost walking ability when the anti-rejection treatment was stopped, but the other continued to walk well for five months until succumbing to pneumonia. That's a common fate for dogs with the genetic condition because of weakness in breathing muscles.

Cossu said he believed that a human treatment could be directed more at breathing muscles than it was in the dogs.

The cells helped strengthen muscle by fusing with regenerating muscle fibers and pumping out a protein that's missing in dogs with the disease.

___

On the Net:

Nature: http://www.nature.com/nature

Muscular Dystrophy Association: http://www.mda.org

 
Google
Web www.iconocast.com
 
 
 

 

Continue News With: News7 ; News8 ; News9 ; News9A


ADVERTISEMENT

Iconocast is about learning and teaching without borders; we offer eMarketing, Internet Advertising, Internet Marketing, Search Engine Optimization, Search Engine Marketing, Online Branding, and eMarketing News Services. Home

 

 © 2002-2006

Keywords::

Contact Iconocast

Home Page